Cara Therapeutics to Webcast Presentation at 26th Annual Piper Jaffray Healthcare Conference
November 25, 2014 16:01 ET
|
Cara Therapeutics
SHELTON, Conn., Nov. 25, 2014 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...
Cara Therapeutics to Webcast Presentation at 2014 Stifel Healthcare Conference
November 11, 2014 16:01 ET
|
Cara Therapeutics
SHELTON, Conn., Nov. 11, 2014 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...
Cara Therapeutics Reports Third Quarter 2014 Financial Results
November 10, 2014 16:01 ET
|
Cara Therapeutics
Reported positive top-line data from human abuse liability trial for I.V. CR845
Phase 3 registration trials for I.V. CR845 expected to initiate in early 2015
Conference call today at...
Cara Therapeutics to Announce Third Quarter 2014 Financial Results on November 10, 2014
November 03, 2014 16:01 ET
|
Cara Therapeutics
SHELTON, Conn., Nov. 3, 2014 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...
Cara Therapeutics Announces Positive Results From Human Abuse Liability Trial of Peripheral Opioid for Acute Pain, I.V. CR845
October 29, 2014 07:00 ET
|
Cara Therapeutics
Trial meets primary endpoint with I.V. CR845 showing highly statistically significant reductions (p <0.0001) in scores for "drug liking," as well as "feeling high", "overall liking", and "take...
Cara Therapeutics Announces the Unexpected Death of Chief Medical Officer Dr. Robert Medve
October 27, 2014 08:45 ET
|
Cara Therapeutics
SHELTON, Conn., Oct. 27, 2014 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...
Cara Therapeutics to Sponsor Symposium at American Academy of Pain Management 2014 Annual Clinical Meeting
September 17, 2014 08:00 ET
|
Cara Therapeutics
SHELTON, Conn., Sept. 17, 2014 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...
Cara Therapeutics Reports Second Quarter 2014 Financial Results
August 07, 2014 16:01 ET
|
Cara Therapeutics
SHELTON, Conn., Aug. 7, 2014 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...
Cara Therapeutics Initiates Proof-of-Concept Phase II Trial of I.V. CR845 in Uremic Pruritus
August 06, 2014 08:00 ET
|
Cara Therapeutics
Two-part study to evaluate safety, pharmacokinetics and anti-itch effects in hemodialysis patients
Top-line data expected in first half of 2015
SHELTON, Conn., Aug. 6, 2014 (GLOBE...
Cara Therapeutics to Announce Second Quarter 2014 Financial Results on August 7, 2014
July 31, 2014 16:01 ET
|
Cara Therapeutics
SHELTON, Conn., July 31, 2014 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...